Multiple endogenous receptors for growth factors, cytokines, and extracellular matrix components

Multiple endogenous receptors for growth factors, cytokines, and extracellular matrix components is a broad pharmacological classification rather than a single molecular entity. This designation is primarily used in databases like DrugBank to describe the pleiotropic targets of polyanionic drugs such as pentosan polysulfate sodium [DrugBank DB00642]. It encompasses various receptor families, including receptor tyrosine kinases (RTKs) for growth factors like FGF and VEGF, cytokine receptors (e.g., interleukin receptors), and structural components of the extracellular matrix (ECM) such as heparan sulfate proteoglycans [PMC6429135]. These molecules are essential for mediating cellular signals related to growth, inflammation, and tissue repair. Drugs associated with this collective target typically act as competitive inhibitors or molecular decoys. By binding to the heparin-binding domains of ligands, they prevent these ligands from interacting with their high-affinity endogenous receptors, thereby modulating complex signaling cascades [PubMed: 25600960]. This mechanism is particularly relevant in the treatment of chronic inflammatory conditions like interstitial cystitis and degenerative diseases like osteoarthritis, where the drugs help to stabilize the ECM and reduce pro-inflammatory signaling [StatPearls: Pentosan Polysulfate]. Due to its non-specific nature, this entry is often flagged as containing too much information for a single target record, as it represents a functional group of diverse proteins.

Other names

Growth factor receptorsCytokine receptorsExtracellular matrix receptorsHeparin-binding protein receptors

Competitive inhibition of ligand binding to multiple cell surface receptors and extracellular matrix components, thereby modulating downstream signaling pathways involved in inflammation and tissue remodeling.